Faculty

ZHAO Yi

Professor

Dermatology

Beijing Tsinghua Changgung Hospital

zhaoyimd@tsinghua.edu.cn

Education Background

Apr. 2010 – Apr. 2011: Visiting Scholar, Department of Dermatology, Medical University of Vienna, Austria

Sep. 2001 – Jul. 2006: Resident Physician and Chief Resident, Department of Dermatology, Peking University First Hospital

Aug. 2001 – Jul. 2006: Doctor of Medicine (Ph.D.), Dermatology and Venereology, Peking University First Hospital

Sep. 1996 – Jul. 2001: Bachelor of Medicine (B.M.), Clinical Medicine, Peking University Health Science Center

Work Experience

2026.4 – Present: Director, Academic Clinical Program of Dermatology, Tsinghua University

Dec. 2019 – Present: Professor and Chief Physician, Department of Dermatology, Beijing Tsinghua Changgung Hospital; Professor, Clinical Medicine School, Tsinghua University

Dec. 2016 – Dec. 2019: Chief Physician, Department of Dermatology, Beijing Tsinghua Changgung Hospital; Associate Professor, School of Medicine, Tsinghua University

Oct. 2014 – Dec. 2016: Director and Associate Chief Physician, Department of Dermatology, Beijing Tsinghua Changgung Hospital; Associate Professor, School of Medicine, Tsinghua University

Aug. 2014 – Oct. 2014: Associate Professor, Department of Dermatology, Peking University First Hospital

Aug. 2011 – Oct. 2014: Associate Chief Physician, Department of Dermatology, Peking University First Hospital

Aug. 2006 – Aug. 2011: Attending Physician, Department of Dermatology, Peking University First Hospital

Research Interests

1. Pathogenesis and precision diagnosis/treatment of inflammatory skin diseases

2. Research on photodiagnostic and phototherapeutic technologies for skin diseases

Representative Publications

1. Peng R, Shi M, Li Y, Xue J, Zhou EY, Wang Y, et al. Aberrant B-cell and cytotoxic T-cell activation in female-pattern hair loss: A pilot comparative clinico-transcriptomic study. Journal of Investigative Dermatology. 2026 Jun;146(6):1669-1672.e6. doi:10.1016/j.jid.2025.12.017

2. Li B, Sun C, Shi M, Yang G, Sun T, Hao H, et al. Increased risk of superficial fungal infections with interleukin 17 inhibitors in psoriasis vulgaris: A retrospective cohort study. Journal of the American Academy of Dermatology. 2026 Aug;95(2):503–5. doi:10.1016/j.jaad.2026.04.002

3. Li B, Han Y, Sun C, Shi M, Ran X, Wang Y, et al. Risk of type 2 inflammation-related diseases during interleukin-17 inhibitor treatment for patients with psoriasis: a retrospective cohort study. British Journal of Dermatology. 2026 Aug 18;195(3):510–2. doi:10.1093/bjd/ljag186

4. Gao Y, Bi Y, Zhou EY, Li Z, Ren J, Zhao Y. A pilot randomized split-face trial comparing fractional Q-Switched ruby laser and 1064-nm Q-Switched nd: YAG laser in Chinese women with melasma running titile: fQSRL vs. QSNY in melasma. Lasers Med Sci. 2025 Oct 4;40(1):405. doi:10.1007/s10103-025-04626-1 PubMed PMID: 41044286.

5. Ren J, Tuan H, Huang C, Shu D, Chen D, Zhou EY, et al. A proposed scoring system for facial port‐wine stain evaluation: Facial port‐wine stain area and severity index. J of Cosmetic Dermatology. 2022 Jul;21(7):2931–8. doi:10.1111/jocd.14574

6. Shu D, Zhang Z, Zhou EY, Ma X, Zhao Y. Is chemoprophylaxis necessary for all latent tuberculosis infection patients receiving IL ‐17 inhibitors? A cohort study. Dermatologic Therapy. 2020 Nov;33(6). doi:10.1111/dth.14512

7. Tuan H, Kang L, Zhou EY, Chen D, Liu D, Shu D, et al. Xanthoma disseminatum effectively treated with 2-chlorodeoxyadenosin (cladribine): a Chinese case series and mini review of the literature. Eur J Dermatol. 2019 Oct 1;29(5):538–9. doi:10.1684/ejd.2019.3629 PubMed PMID: 31591984.

8. Zhao Y, Tu P, Zhou G, Zhou Z, Lin X, Yang H, et al. Hemoporfin Photodynamic Therapy for Port-Wine Stain: A Randomized Controlled Trial. PLoS ONE. 2016;11(5):e0156219. doi:10.1371/journal.pone.0156219 PubMed PMID: 27227544; PubMed Central PMCID: PMC4881994.

9. Zhao Y, Li CY, Wen CM, Wei YB, Li RY, Wang G, et al. The prevalence of actinic keratoses in the patients visiting dermatologists in two hospitals of China. Br J Dermatol. 2015 Dec 9. doi:10.1111/bjd.14344 PubMed PMID: 26650251.

10. Zhao Y, Zhang CF, Rossiter H, Eckhart L, Konig U, Karner S, et al. Autophagy is induced by UVA and promotes removal of oxidized phospholipids and protein aggregates in epidermal keratinocytes. J Invest Dermatol. 2013 Jun;133(6):1629–37. doi:10.1038/jid.2013.26 PubMed PMID: 23340736.

Academic Honors & Awards

2025 Beijing Science and Technology Progress Award, Second Prize

2016 Outstanding Young Physician of the Capital (Beijing)

Academic Appointments

  • Full Member, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)

  • Director, Asia Society for Psoriasis

  • Vice Chair, Laser Aesthetics Branch, Chinese Association of Plastics and Aesthetics

  • Secretary-General, Intelligent Medicine Committee, Chinese Medical Doctor Association

  • Standing Committee Member, Dermatology Branch, Beijing Medical Association

TOP